• Valeriana Dispert 125 mg 20 coated tablets
1 1

Vemedia

Valeriana Dispert 125 mg 20 coated tablets

Valeriana Dispert 125 mg 20 coated tablets

€16,28
€17,50 €16,28
Sale Sold out
Taxes included. Shipping calculated at checkout.
Logo Farmaci da banco

NET WEIGHT OF THE PRODUCT

20ct

EAN

004853053

MINSAN

004853053

View full details

In compliance with article 118 "authorization of advertising to the public" of the legislative decree of 24 April 2006, number 219

INDICATIONS

Herbal medicine for the treatment of states of mild and temporary nervous tension and temporary difficulty in falling asleep (see Section 4.4 Special warnings and precautions for use).

CONTRAINDICATIONS

Hypersensitivity to the active substance or to any of the excipients listed in paragraph 6.1. Use in children under 12 years of age is not recommended, as no data are available on the efficacy and safety of the drug in pediatrics. Generally contraindicated during pregnancy and breastfeeding.

WARNINGS AND PRECAUTIONS FOR USE

Consult your doctor if symptoms persist for more than 2 weeks or if they worsen during treatment. Valerian DISPERT contains lactose: Patients suffering from rare hereditary problems of galactose intolerance, Lapp lactase deficiency or glucose-galactose malabsorption should not take this medicine. Valerian DISPERT contains sucrose: Patients suffering from rare hereditary problems of fructose intolerance, glucose-galactose malabsorption, or sucrase isomaltase insufficiency should not take this medicine.

INTERACTIONS

No interactions have been reported. The patient is however invited to ask his doctor for advice if he is taking other medicines.

SIDE EFFECTS

There are no known side effects that can be attributed to the use of the medicine under the recommended conditions and for short periods of time. Reporting of suspected adverse reactions Reporting suspected adverse reactions that occur after authorization of the medicine is important, as it allows continuous monitoring of the benefit/risk balance of the medicine. Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system at www.agenziafarmaco.gov.it/it/responsabili.

OUR PRODUCTS FOR THIS SEASON

1 10
View all
1 4

Content Responsibility This sheet contains information that is not intended to replace a diagnosis or medical advice, as only the doctor can draw up any prescription and give therapeutic indications. All contents must be understood and are of an exclusively informative nature and aimed exclusively at bringing to the attention of customers or potential customers in the pre-purchase phase of the products sold through this site. In case of pathologies, disorders or allergies it is always best to consult your doctor first. Please note The names of the products, the ingredients and the percentages indicated in the descriptions are purely indicative, they may be subject to changes or updates by the manufacturing companies. Due to the impossibility of adapting in real time to such updates, the photos and technical information of the products inserted on Dottortili.com may differ from those reported on the label or otherwise disseminated by the manufacturing companies. The only identification element is the MINSAN ministerial code. The online pharmacy Dottortili.com does not guarantee the truthfulness and timeliness of the information published and declines all responsibility for any errors, omissions or failure to update the same. Dottortili.com does not assume responsibility for damages of any nature that may arise from access to the information published. Data source: Farmadati Italia Website: www.farmadati.it The Farmadati Italia Database is used by almost all pharmacies, parapharmacies, herbalist shops, health shops, large-scale retail trade, computerized doctors, etc. thanks to the company's historical guarantee of reliability, seriousness and professionalism on the national territory. The Farmadati Italia Srl management system complies with the requirements of the UNI EN ISO 9001:2015 standards for quality management systems and UNI CEI ISO/IEC 27001:2017 for information security management systems.